Profit machinery upgraded while volume still arriving

SOPHiA GENETICS SA (SOPH) — this company's answers

The model's full reasoning — Q4 2021 call → NOWe need to answer YES or NO based on the transcript. The question asks: does management convey that the company has ALREADY ACHIEVED A STRUCTURAL IMPROVEMENT IN HOW MUCH IT KEEPS FROM EACH UNIT OF BUSINESS — through changes the company itself made that are now visible in the recent period's actual results — AND that business volume is SIMULTANEOUSLY GROWING onto that improved structure, so each arriving increment converts to profit at the new, better rate with most of that arriving volume still ahead of the reported results? We need to check both halves. First, a realized, company-made step-up in per-unit economics. Look for evidence in the transcript. Management talks about revenue growth, but do they mention a structural improvement in per-unit economics? They mention net dollar retention rate of 142%, which is high, but that's about retention and expansion, not necessarily a step-up in per-unit economics. They mention average revenue per platform customer increased to $92,000 from $70,000, which is a per-unit increase. But is that attributed to company actions? They say "The growth in revenue was primarily driven by new customers added to our platform coupled with increased usage rates across our existing customers." That suggests volume growth, not necessarily a structural change in per-unit economics. They also mention "land and expand" strategy, but that's about increasing utilization, which is volume per customer, not necessarily a structural improvement in margin per unit. They don't explicitly talk about a rebuilt cost structure or a changed delivery model that improves per-unit economics. They talk about gross margin being 62% in Q4, in line with prior year, so no improvement there. Adjusted gross margin was 65% for Q4 and 64% for full year, so slight improvement but not a step-up. They don't mention any structural change like moving to a more profitable mix or pricing power. They mention new products like HRD and CarePath, but those are future opportunities, not yet realized in the recent period's results. So the first half seems not clearly conveyed. Second half: volume arriving now and early. They do talk about strong growth, new customers, increased utilization, and they have guidance for 2022 with growth of 27-33%.

← Back to the full SOPH analysis